537 related articles for article (PubMed ID: 33159483)
1. The calcium channel TRPV6 is a novel regulator of RANKL-induced osteoclastic differentiation and bone absorption activity through the IGF-PI3K-AKT pathway.
Ma J; Zhu L; Zhou Z; Song T; Yang L; Yan X; Chen A; Ye TW
Cell Prolif; 2021 Jan; 54(1):e12955. PubMed ID: 33159483
[TBL] [Abstract][Full Text] [Related]
2. Knockout of TRPV6 causes osteopenia in mice by increasing osteoclastic differentiation and activity.
Chen F; Ni B; Yang YO; Ye T; Chen A
Cell Physiol Biochem; 2014; 33(3):796-809. PubMed ID: 24686448
[TBL] [Abstract][Full Text] [Related]
3. PDK1 is important lipid kinase for RANKL-induced osteoclast formation and function via the regulation of the Akt-GSK3β-NFATc1 signaling cascade.
Xiao D; Zhou Q; Gao Y; Cao B; Zhang Q; Zeng G; Zong S
J Cell Biochem; 2020 Nov; 121(11):4542-4557. PubMed ID: 32048762
[TBL] [Abstract][Full Text] [Related]
4. Estrogen inhibits RANKL-induced osteoclastic differentiation by increasing the expression of TRPV5 channel.
Chen F; Ouyang Y; Ye T; Ni B; Chen A
J Cell Biochem; 2014 Apr; 115(4):651-8. PubMed ID: 24150765
[TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect and the molecular mechanism of glabridin on RANKL-induced osteoclastogenesis in RAW264.7 cells.
Kim HS; Suh KS; Sul D; Kim BJ; Lee SK; Jung WW
Int J Mol Med; 2012 Feb; 29(2):169-77. PubMed ID: 22038020
[TBL] [Abstract][Full Text] [Related]
6. Cholesterol inhibits autophagy in RANKL-induced osteoclast differentiation through activating the PI3K/AKT/mTOR signaling pathway.
Jiang C; Wang Y; Zhang M; Xu J
Mol Biol Rep; 2022 Oct; 49(10):9217-9229. PubMed ID: 35881223
[TBL] [Abstract][Full Text] [Related]
7. Diaporisoindole E inhibits RANKL-induced osteoclastogenesis via suppression of PI3K/AKT and MAPK signal pathways.
Hua P; Cui H; Xu J; Cai R; She Z; Gu Q
Phytomedicine; 2020 Aug; 75():153234. PubMed ID: 32510335
[TBL] [Abstract][Full Text] [Related]
8. WHI-131 Promotes Osteoblast Differentiation and Prevents Osteoclast Formation and Resorption in Mice.
Cheon YH; Kim JY; Baek JM; Ahn SJ; Jun HY; Erkhembaatar M; Kim MS; Lee MS; Oh J
J Bone Miner Res; 2016 Feb; 31(2):403-15. PubMed ID: 26255791
[TBL] [Abstract][Full Text] [Related]
9. Cytisine attenuates bone loss of ovariectomy mouse by preventing RANKL-induced osteoclastogenesis.
Qian Z; Zhong Z; Ni S; Li D; Zhang F; Zhou Y; Kang Z; Qian J; Yu B
J Cell Mol Med; 2020 Sep; 24(17):10112-10127. PubMed ID: 32790170
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.
Okayasu M; Nakayachi M; Hayashida C; Ito J; Kaneda T; Masuhara M; Suda N; Sato T; Hakeda Y
J Biol Chem; 2012 Jun; 287(23):19229-41. PubMed ID: 22500026
[TBL] [Abstract][Full Text] [Related]
11. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
[TBL] [Abstract][Full Text] [Related]
12. Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways.
Yuan FL; Xu RS; Jiang DL; He XL; Su Q; Jin C; Li X
Bone; 2015 Jun; 75():128-37. PubMed ID: 25708053
[TBL] [Abstract][Full Text] [Related]
13. The loss of Cbl-phosphatidylinositol 3-kinase interaction perturbs RANKL-mediated signaling, inhibiting bone resorption and promoting osteoclast survival.
Adapala NS; Barbe MF; Langdon WY; Nakamura MC; Tsygankov AY; Sanjay A
J Biol Chem; 2010 Nov; 285(47):36745-58. PubMed ID: 20851882
[TBL] [Abstract][Full Text] [Related]
14. Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca
Baek JM; Kim JY; Lee CH; Yoon KH; Lee MS
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272351
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of TRPV4 suppresses osteoclast differentiation and osteoporosis by inhibiting autophagy through Ca
Cao B; Dai X; Wang W
J Cell Physiol; 2019 May; 234(5):6831-6841. PubMed ID: 30387123
[TBL] [Abstract][Full Text] [Related]
16. Antiosteoclastic bone resorption activity of osteoprotegerin via enhanced AKT/mTOR/ULK1-mediated autophagic pathway.
Zhao H; Sun Z; Ma Y; Song R; Yuan Y; Bian J; Gu J; Liu Z
J Cell Physiol; 2020 Mar; 235(3):3002-3012. PubMed ID: 31535378
[TBL] [Abstract][Full Text] [Related]
17. Thioacetamide promotes osteoclast transformation of bone marrow macrophages by influencing PI3K/AKT pathways.
Jin X; Li Y; Yang Y; Shen H; Chen J; Xu B; Xu J
J Orthop Surg Res; 2022 Jan; 17(1):53. PubMed ID: 35093114
[TBL] [Abstract][Full Text] [Related]
18. AZD8835 inhibits osteoclastogenesis and periodontitis-induced alveolar bone loss in rats.
Wang Y; Chen X; Chen X; Zhou Z; Xu W; Xu F; Zhang S
J Cell Physiol; 2019 Jul; 234(7):10432-10444. PubMed ID: 30652303
[TBL] [Abstract][Full Text] [Related]
19. Microtubule actin crosslinking factor 1 (MACF1) knockdown inhibits RANKL-induced osteoclastogenesis via Akt/GSK3β/NFATc1 signalling pathway.
Lin X; Xiao Y; Chen Z; Ma J; Qiu W; Zhang K; Xu F; Dang K; Qian A
Mol Cell Endocrinol; 2019 Aug; 494():110494. PubMed ID: 31260729
[TBL] [Abstract][Full Text] [Related]
20. miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway.
Zhao C; Sun W; Zhang P; Ling S; Li Y; Zhao D; Peng J; Wang A; Li Q; Song J; Wang C; Xu X; Xu Z; Zhong G; Han B; Chang YZ; Li Y
RNA Biol; 2015; 12(3):343-53. PubMed ID: 25826666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]